Browse > Article

Periocular Allergic Contact Dermatitis Associated with the Use of Ofloxacin Ophthalmic Ointment: A Case Report  

Jo, Jeong Won (Department of Dermatology, Gyeongsang National University School of Medicine)
Jeong, Hae Bong (Department of Dermatology, Gyeongsang National University School of Medicine)
Shin, Young Bin (Department of Dermatology, Gyeongsang National University School of Medicine)
Kang, Kee Ryeon (Department of Biochemistry, Gyeongsang National University School of Medicine)
Kim, Chi Yeon (Department of Dermatology, Gyeongsang National University School of Medicine)
Publication Information
Korean journal of dermatology / v.56, no.10, 2018 , pp. 624-627 More about this Journal
Abstract
Allergic contact dermatitis is an inflammatory condition associated with periorbital erythema, edema, and pruritus. The periorbital skin is relatively thin compared with the skin over other facial areas; therefore, it is vulnerable to allergen penetration and may show a variety of cutaneous manifestations. Recently, vision enhancement surgery is a widely performed procedure, and the prevalence of senile cataract and glaucoma is increasing. The prevalence of periocular allergic contact dermatitis is increasing secondary to the growing use of topical ophthalmic medications. Several studies in Korea have reported periocular allergic contact dermatitis secondary to the use of topical ophthalmic medications including latanoprost ($Latano^{(R)}$), fluorometholone ($Tolon^{(R)}$), polymyxin B ($Terramycin^{(R)}$), atropine sulfate ($Atropine^{(R)}$), neomycin sulfate ($Cambison^{(R)}$), and befunolol hydrochloride ($Bentos^{(R)}$), among others. However, ofloxacin ($Effexin^{(R)})$-induced allergic contact dermatitis has not been reported in the domestic and/or foreign literature. We report a case of periocular allergic contact dermatitis secondary to the use of ofloxacin ophthalmic ointment.
Keywords
Allergic contact dermatitis; Ofloxacin; Ophthalmic ointment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Valsecchi R, Imberti G, Martino D, Cainelli T. Eyelid dermatitis: an evaluation of 150 patients. Contact Dermatitis 1992:27:143-147   DOI
2 Landeck L, John SM, Geier J. Topical ophthalmic agents as allergens in periorbital dermatitis. Br J Ophthalmol 2014;98:259-262   DOI
3 Landeck L, John SM, Geier J. Periorbital dermatitis in 4779 patients-patch test results during a 10-year period. Contact Dermatitis 2013;70:205-212
4 Ayala F, Fabbrocini G, Bacchilega R, Berardesca E, Caraffini S, Corazza M, et al. Eyelid dermatitis: an evaluation of 447 patients. Am J Contact Dermat 2003;14:69-74   DOI
5 Lee HB, Chung BY, Ahn IS, Kim HO, Park CW, Lee CH. Allergic contact dermatitis on the periorbital area: report of three cases. Korean J Dermatol 2010;48:429-434
6 You YH, Lee JY, Kim HO, Kim CW. A case of contact dermatitis due to chloramphenicol. Korean J Dermatol 1994;32:703-706
7 Hatinen A, Terasvirta M, Fraki JE. Contact allergy to components in topical ophthalmologic preparations. Acta Ophthalmol 1985;63:424-426
8 Kim JM, Kim GW, Mun JH, Song Margaret, Kim HS, Kim BS, et al. Patch testing to determine causative contact allergens in patients with periocular dermatitis. Korean J Dermatol 2014;52:548-553
9 Venturini M, Lobera T, del Pozo MD, Blasco A, Gonzalez I. In vivo diagnostic tests in adverse reactions to quinolones. J Investig Allergol Clin Immunol 2007;17:393-398
10 Ramani YR, Mishra SK, Rath B, Rath SS. Ofloxacin induced cutaneous reactions in children. J Clin Diagn Res 2015;9(6):FD01-2   DOI
11 Schnuch A, Lessmann H, Geier J, Uter W. White petrolatum (Ph. Eur.) is virtually non-sensitizing. Analysis of IVDK data on 80000 patients tested between 1992 and 2004 and short discussion of identification and designation of allergens. Contact Dermatitis 2006;54:338-343   DOI
12 Mendelow AY, Forsyth A, Baillie AJ, Florence AT. In vitro release of nickel sulphate of varying particle size from paraffin bases. Int J Pharm 1989;49(1):29-37   DOI
13 Zheng Y, Chaudhari PR, Maibach HI. Allergic contact dermatitis from ophthalmics. Cutan Ocul Toxicol 2017;6:1-4